Spontaneous resolution of lupus nephritis following withdrawal of etanercept

Ann Clin Lab Sci. 2013 Fall;43(4):447-9.

Abstract

Introduction: Etanercept, a systemic inhibitor of α-TNF, is used for treatment of various autoimmune disorders. We report a case of spontaneous resolution of etanercept-induced lupus nephritis.

Case description: A 57-year-old female patient taking etanercept for psoriasis presented with laboratory-and histology-confirmed lupus nephritis. After stopping etanercept, there was normalization of proteinuria, hematuria, serum complements, anti-dsDNA antibody, and resolution of the acute glomerular inflammatory process on repeat kidney biopsy.

Conclusion: This case demonstrates serology- and biopsy-confirmed resolution of active lupus nephritis upon withdrawal of etanercept.

Keywords: etanercept; glomerulonephritis; kidney biopsy; lupus nephritis.

Publication types

  • Case Reports

MeSH terms

  • Autoantibodies / drug effects
  • Autoantibodies / immunology*
  • Blood Chemical Analysis
  • Creatine / blood
  • Etanercept
  • Female
  • Humans
  • Immunoglobulin G / adverse effects*
  • Immunoglobulin G / therapeutic use
  • Kidney / ultrastructure
  • Lupus Nephritis / chemically induced*
  • Lupus Nephritis / pathology*
  • Microscopy, Electron
  • Middle Aged
  • Psoriasis / drug therapy
  • Receptors, Tumor Necrosis Factor / therapeutic use
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors
  • Urinalysis

Substances

  • Autoantibodies
  • Immunoglobulin G
  • Receptors, Tumor Necrosis Factor
  • Tumor Necrosis Factor-alpha
  • Creatine
  • Etanercept